Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

The impact of screening for Type 2 diabetes in siblings of patients with established diabetes.

Farmer AJ, Doll H, Levy JC, Salkovskis PM.

Diabet Med. 2003 Dec;20(12):996-1004.

PMID:
14632700
2.

In a randomized trial, outcomes were not affected by intensive follow-up over 1 year.

Farmer AJ, Doll HA.

J Clin Epidemiol. 2005 Oct;58(10):991-6.

PMID:
16168344
3.

No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study.

Adriaanse MC, Snoek FJ, Dekker JM, Spijkerman AM, Nijpels G, Twisk JW, van der Ploeg HM, Heine RJ.

Diabet Med. 2004 Sep;21(9):992-8.

PMID:
15317604
4.

Knowledge of risk of developing diabetes mellitus among siblings of Type 2 diabetic patients.

Farmer AJ, Levy JC, Turner RC.

Diabet Med. 1999 Mar;16(3):233-7.

PMID:
10227569
5.

Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ).

Nicolucci A, Giorgino R, Cucinotta D, Zoppini G, Muggeo M, Squatrito S, Corsi A, Lostia S, Pappalardo L, Benaduce E, Girelli A, Galeone F, Maldonato A, Perriello G, Pata P, Marra G, Coronel GA.

Diabetes Nutr Metab. 2004 Aug;17(4):235-43.

PMID:
15575345
6.
7.

Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark.

Mai KS, Sandbaek A, Borch-Johnsen K, Lauritzen T.

Diabet Med. 2007 Oct;24(10):1121-8. Epub 2007 Aug 24.

PMID:
17725631
8.

The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.

Shephard MD, Mazzachi BC, Shephard AK, McLaughlin KJ, Denner B, Barnes G.

Rural Remote Health. 2005 Jul-Sep;5(3):371. Epub 2005 Jul 15.

9.

Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.

Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, Tognoni G, Valentini M, Nicolucci A.

Diabetes Care. 2005 May;28(5):1187-94.

PMID:
15855587
10.

Discover diabetes: screening for diabetes mellitus in the Waikato.

Lawrenson RA, Dunn PJ, Jury D, Sceats J.

N Z Med J. 1993 Dec 8;106(969):522-4.

PMID:
8183493
11.

Maternal psychological reaction to newborn genetic screening for type 1 diabetes.

Kerruish NJ, Campbell-Stokes PL, Gray A, Merriman TR, Robertson SP, Taylor BJ.

Pediatrics. 2007 Aug;120(2):e324-35. Epub 2007 Jul 3.

PMID:
17609310
12.

Risk and prevention of type II diabetes: offspring's views.

Pierce M, Harding D, Ridout D, Keen H, Bradley C.

Br J Gen Pract. 2001 Mar;51(464):194-9.

13.

Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.

Nichols GA, Hillier TA, Brown JB.

Am J Med. 2008 Jun;121(6):519-24. doi: 10.1016/j.amjmed.2008.02.026.

PMID:
18501234
14.

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.

Brindle LA, Oliver SE, Dedman D, Donovan JL, Neal DE, Hamdy FC, Lane JA, Peters TJ.

BJU Int. 2006 Oct;98(4):777-82.

15.

[Tuberculosis in compromised hosts].

[No authors listed]

Kekkaku. 2003 Nov;78(11):717-22. Japanese.

PMID:
14672050
16.

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.

PMID:
17669232
17.

Maternal anxiety associated with newborn genetic screening for type 1 diabetes.

Bennett Johnson S, Baughcum AE, Carmichael SK, She JX, Schatz DA.

Diabetes Care. 2004 Feb;27(2):392-7.

PMID:
14747219
19.

Women's experiences of being screened for gestational diabetes mellitus.

Rumbold AR, Crowther CA.

Aust N Z J Obstet Gynaecol. 2002 May;42(2):131-7.

PMID:
12069138
20.

Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension.

Lim HS, Lip GY, Beevers DG, Blann AD.

Eur J Clin Invest. 2005 May;35(5):324-9.

PMID:
15860044

Supplemental Content

Support Center